![Risk of dying from cancer varies widely across regions in England](http://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1702034431467_featurenews2012_x1.jpg)
![shadow](http://www.imperial.ac.uk/assets/news/img/image_shadow_sidebar.png)
CANCER RISK
Risk of dying from cancer varies widely across regions in England
The risk of dying of cancer in England varies hugely depending on where people live, according to new research led by Imperial.
Risk of dying from cancer varies widely across regions in England
The risk of dying of cancer in England varies hugely depending on where people live, according to new research led by Imperial.
Haircare science and solar cells: News from Imperial
Here's a batch of fresh news and announcements from across Imperial.
Largest study of its kind shows leafy greens may decrease bowel cancer risk
Increasing the amount of folate through our diet or taking supplements could help to reduce bowel cancer risk.
Prostate cancer focal therapy is cost effective and may improve patient outcomes
Minimally invasive focal therapies for prostate cancer are associated with a lower overall cost and improved quality of life for patients.
UK Government backs Fleming Centre to fight threat of drug resistant infections
The UK Government has committed £5million in seed funding to support a joint Imperial initiative to fight antimicrobial resistance.
UK approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders.
Heart stents may offer alternative to chest pain medication for angina patients
Some patients with chest pain from reduced blood flow to the heart may benefit from having a stent implanted, instead of chest pain medications.
Number of extremely premature babies receiving neonatal care triples
The number of babies born at 22 weeks given respiratory life support in England and Wales increased three-fold after NHS guidelines changed in 2019.
AI stethoscope rolled out to 100 GP clinics to help diagnose heart failure
GP clinics in London and Wales will receive an AI-powered tool as part of a trial to help improve the diagnosis of a deadly heart condition.
Statin benefits patients with severe COVID-19 while vitamin C is ‘ineffective'
A common cholesterol-lowering drug may improve outcomes for critically ill patients with COVID-19, while high dose vitamin C is ineffective.